Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Gestational Diabetes Therapeutics Clinical Trials 27 Prominent Drugs 29 Clinical Trial Profile Snapshots 30 Appendix 105 Abbreviations 105 Definitions 105 Research Methodology 106 Secondary Research 106 About GlobalData 107 Contact Us 107 Disclaimer 107 Source 108

List of Tables Gestational Diabetes Therapeutics, Global, Clinical Trials by Region, 2016* 6 Gestational Diabetes Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Gestational Diabetes Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Gestational Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Gestational Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Gestational Diabetes Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Gestational Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12 Gestational Diabetes Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13 Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 14 Gestational Diabetes Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Gestational Diabetes Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 17 Gestational Diabetes Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Gestational Diabetes Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Gestational Diabetes Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Gestational Diabetes Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Gestational Diabetes Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Gestational Diabetes Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Gestational Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Gestational Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Gestational Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Gestational Diabetes Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29 List of Figures Gestational Diabetes Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Gestational Diabetes Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Gestational Diabetes Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Gestational Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Gestational Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Gestational Diabetes Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Gestational Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12 Gestational Diabetes Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13 Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 14 Gestational Diabetes Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Gestational Diabetes Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 17 Gestational Diabetes Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Gestational Diabetes Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Gestational Diabetes Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Gestational Diabetes Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Gestational Diabetes Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Gestational Diabetes Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Gestational Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Gestational Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Gestational Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Gestational Diabetes Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29 GlobalData Methodology 106

Novo A/S Pharmarte srl Merck & Co., Inc. Kavery Medical Centre and Hospitals Ltd. Fonds de recherche du Quebec Eli Lilly and Company E. Merck KG CD Pharma India Private Ltd. AstraZeneca Plc Arkray, Inc.